Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: Release date June 2013 SFP Guideline #20133

Jamila B. Perritt, Anne Burke, Alison B. Edelman

Research output: Contribution to journalArticle

Abstract

The need to interrupt a pregnancy between 24 and 28 weeks of gestation is uncommon and is typically due to fetal demise or lethal anomalies. Nonetheless, treatment options become more limited at these gestations, when access to surgical methods may not be available in many circumstances. The efficacy of misoprostol with or without mifepristone has been well studied in the first and earlier second trimesters of pregnancy, but its use beyond 24 weeks' gestation is less well described. This document attempts to synthesize the existing evidence for the use of misoprostol with or without mifepristone to induce labor for nonviable pregnancies at gestations of 24-28 weeks. The composite evidence suggests that a regimen combining mifepristone and misoprostol may shorten the time to expulsion, though the overall success rates are similar to those seen with misoprostol-only regimens.

Original languageEnglish (US)
Pages (from-to)341-349
Number of pages9
JournalContraception
Volume88
Issue number3
DOIs
StatePublished - Sep 2013
Externally publishedYes

Fingerprint

Misoprostol
Guidelines
Mifepristone
Pregnancy
Fetal Death
Second Pregnancy Trimester
spleen fibrinolytic proteinase (human)

Keywords

  • Abortion
  • Fetal anomaly
  • Fetal demise
  • Intrauterine fetal death
  • Labor induction
  • Labor termination
  • Medical abortion: induced abortion
  • Midtrimester
  • Mifepristone
  • Misoprostol
  • Pregnancy termination
  • Second-trimester abortion
  • Third-trimester abortion

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods : Release date June 2013 SFP Guideline #20133. / Perritt, Jamila B.; Burke, Anne; Edelman, Alison B.

In: Contraception, Vol. 88, No. 3, 09.2013, p. 341-349.

Research output: Contribution to journalArticle

@article{d91bb1127f51423a8fac5370bf03848b,
title = "Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: Release date June 2013 SFP Guideline #20133",
abstract = "The need to interrupt a pregnancy between 24 and 28 weeks of gestation is uncommon and is typically due to fetal demise or lethal anomalies. Nonetheless, treatment options become more limited at these gestations, when access to surgical methods may not be available in many circumstances. The efficacy of misoprostol with or without mifepristone has been well studied in the first and earlier second trimesters of pregnancy, but its use beyond 24 weeks' gestation is less well described. This document attempts to synthesize the existing evidence for the use of misoprostol with or without mifepristone to induce labor for nonviable pregnancies at gestations of 24-28 weeks. The composite evidence suggests that a regimen combining mifepristone and misoprostol may shorten the time to expulsion, though the overall success rates are similar to those seen with misoprostol-only regimens.",
keywords = "Abortion, Fetal anomaly, Fetal demise, Intrauterine fetal death, Labor induction, Labor termination, Medical abortion: induced abortion, Midtrimester, Mifepristone, Misoprostol, Pregnancy termination, Second-trimester abortion, Third-trimester abortion",
author = "Perritt, {Jamila B.} and Anne Burke and Edelman, {Alison B.}",
year = "2013",
month = "9",
doi = "10.1016/j.contraception.2013.05.001",
language = "English (US)",
volume = "88",
pages = "341--349",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods

T2 - Release date June 2013 SFP Guideline #20133

AU - Perritt, Jamila B.

AU - Burke, Anne

AU - Edelman, Alison B.

PY - 2013/9

Y1 - 2013/9

N2 - The need to interrupt a pregnancy between 24 and 28 weeks of gestation is uncommon and is typically due to fetal demise or lethal anomalies. Nonetheless, treatment options become more limited at these gestations, when access to surgical methods may not be available in many circumstances. The efficacy of misoprostol with or without mifepristone has been well studied in the first and earlier second trimesters of pregnancy, but its use beyond 24 weeks' gestation is less well described. This document attempts to synthesize the existing evidence for the use of misoprostol with or without mifepristone to induce labor for nonviable pregnancies at gestations of 24-28 weeks. The composite evidence suggests that a regimen combining mifepristone and misoprostol may shorten the time to expulsion, though the overall success rates are similar to those seen with misoprostol-only regimens.

AB - The need to interrupt a pregnancy between 24 and 28 weeks of gestation is uncommon and is typically due to fetal demise or lethal anomalies. Nonetheless, treatment options become more limited at these gestations, when access to surgical methods may not be available in many circumstances. The efficacy of misoprostol with or without mifepristone has been well studied in the first and earlier second trimesters of pregnancy, but its use beyond 24 weeks' gestation is less well described. This document attempts to synthesize the existing evidence for the use of misoprostol with or without mifepristone to induce labor for nonviable pregnancies at gestations of 24-28 weeks. The composite evidence suggests that a regimen combining mifepristone and misoprostol may shorten the time to expulsion, though the overall success rates are similar to those seen with misoprostol-only regimens.

KW - Abortion

KW - Fetal anomaly

KW - Fetal demise

KW - Intrauterine fetal death

KW - Labor induction

KW - Labor termination

KW - Medical abortion: induced abortion

KW - Midtrimester

KW - Mifepristone

KW - Misoprostol

KW - Pregnancy termination

KW - Second-trimester abortion

KW - Third-trimester abortion

UR - http://www.scopus.com/inward/record.url?scp=84883456694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883456694&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2013.05.001

DO - 10.1016/j.contraception.2013.05.001

M3 - Article

C2 - 23756114

AN - SCOPUS:84883456694

VL - 88

SP - 341

EP - 349

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 3

ER -